semaglutide compound lawsuit Hims & Hers Health will stop selling GLP-1 to settle Judge Upholds FDA Deadline Ending

NDA filing expected Q4 2026

Because Retatrutide is a GLP-1-class agonist, the well-established class safety warnings apply as reference context: Thyroid C-cell tumors / MTC (boxed-warning class effect): GLP-1 receptor agonists carry a boxed warning for thyroid C-cell tumors based on rodent data

It can, particularly insulin and sulfonylureas (raising low-blood-sugar risk in people with diabetes) and oral medications whose absorption is affected by slower digestion

Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients

Never share vials between patients, including family members, as this violates sterility protocols and poses a risk of infection transmission

Rate-Limiting Substrate Modules Governing Adaptation Under Chronic Flux Constriction GLP-1RA therapy imposes a sustained reduction in nutrient inflow while maintaining or redistributing oxidative throughput (Sect